In 2005, BioVeda China Fund (BVCF) Management Ltd became the first private equity firm specialized and dedicated to China’s healthcare and life sciences industries. BVCF supports Chinese entrepreneurs who are active in the development of innovative and affordable pharmaceutical products and services, and have a global scope. SIFEM invested in BVCF’s third fund, BVCF III, in 2014.
